Quest Diagnostics Incorporated (DGX)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 138.16 |
| Open | 138.12 |
| Bid | 138.64 x 900 |
| Ask | 138.71 x 1100 |
| Day's range | 137.40 - 138.96 |
| 52-week range | 119.59 - 145.58 |
| Volume | |
| Avg. volume | 976,633 |
| Market cap | 15.377B |
| Beta (5Y monthly) | 0.87 |
| PE ratio (TTM) | 18.63 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.00 (2.17%) |
| Ex-dividend date | 05 Apr 2024 |
| 1y target est | N/A |
- Zacks
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
- Zacks
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
- Zacks
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
© 2024 Yahoo. All rights reserved.